glp 1 breast feeding GSLIM — Natural GLP-1 Supplement GLP-1 and Breastfeeding: Safety Evidence

NICE issued a positive technology appraisal for semaglutide in 2023 , with NHS England targeting 35,000 patients in initial specialist weight management services

Little TJ, Pilichiewicz AN, Russo A, et al

Conclusions GLP-1 agonists reduce fetal survival, weight, growth and skeletal ossification and can induce major congenital anomalies

Functional and Clinical Relevance of Novel and Known PCSK1 Variants for Childhood Obesity and Glucose Metabolism. Molecular Metabolism, vol

E., & Flood, J

To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data